Home/Filings/4/0001209191-18-006751
4//SEC Filing

Baker Kevin Paul 4

Accession 0001209191-18-006751

CIK 0001175505other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 3:13 PM ET

Size

4.6 KB

Accession

0001209191-18-006751

Insider Transaction Report

Form 4
Period: 2018-02-01
Baker Kevin Paul
SVP, Development Sciences
Transactions
  • Tax Payment

    Common Stock

    2018-02-01$19.73/sh18,866$372,22675,614 total

Issuer

FIVE PRIME THERAPEUTICS INC

CIK 0001175505

Entity typeother

Related Parties

1
  • filerCIK 0001664512

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 3:13 PM ET
Size
4.6 KB